225 related articles for article (PubMed ID: 38071654)
1. Defining interventions and metrics to improve diversity in CNS clinical trial participation: A SNO and RANO effort.
Budhu JA; Chukwueke UN; Jackson S; Lee EQ; McFaline-Figueroa JR; Willmarth N; Dalmage M; Kawachi I; Arons D; Chang SM; Galanis E; Hervey-Jumper SL; Wen PY; Porter AB
Neuro Oncol; 2024 Apr; 26(4):596-608. PubMed ID: 38071654
[TBL] [Abstract][Full Text] [Related]
2. SNO 2020 diversity survey: defining demographics, racial biases, career success metrics and a path forward for the field of neuro-oncology.
Chukwueke UN; Vera E; Acquaye A; Hervey-Jumper SL; Odia Y; Klesse LJ; Dunbar E; Sharma A; Fonkem E; Thomas AA; Werbowetski-Ogilvie TE; Camelo-Piragua S; Gatson NTN; de la Fuente MI; Armstrong TS; Porter AB; Jackson S
Neuro Oncol; 2021 Nov; 23(11):1845-1858. PubMed ID: 34302487
[TBL] [Abstract][Full Text] [Related]
3. Toward representative genomic research: the children's rare disease cohorts experience.
Frazier ZJ; Brown E; Rockowitz S; Lee T; Zhang B; Sveden A; Chamberlin NL; Dies KA; Poduri A; Sliz P; Chopra M
Ther Adv Rare Dis; 2023; 4():26330040231181406. PubMed ID: 37621556
[TBL] [Abstract][Full Text] [Related]
4. Barriers to accrual and enrollment in brain tumor trials.
Lee EQ; Chukwueke UN; Hervey-Jumper SL; de Groot JF; Leone JP; Armstrong TS; Chang SM; Arons D; Oliver K; Verble K; Musella A; Willmarth N; Alexander BM; Bates A; Doherty L; Galanis E; Gaffey S; Halkin T; Friday BE; Fouladi M; Lin NU; Macdonald D; Mehta MP; Penas-Prado M; Vogelbaum MA; Sahebjam S; Sandak D; van den Bent M; Weller M; Reardon DA; Wen PY
Neuro Oncol; 2019 Sep; 21(9):1100-1117. PubMed ID: 31175826
[TBL] [Abstract][Full Text] [Related]
5. Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement.
Oyer RA; Hurley P; Boehmer L; Bruinooge SS; Levit K; Barrett N; Benson A; Bernick LA; Byatt L; Charlot M; Crews J; DeLeon K; Fashoyin-Aje L; Garrett-Mayer E; Gralow JR; Green S; Guerra CE; Hamroun L; Hardy CM; Hempstead B; Jeames S; Mann M; Matin K; McCaskill-Stevens W; Merrill J; Nowakowski GS; Patel MI; Pressman A; Ramirez AG; Segura J; Segarra-Vasquez B; Hanley Williams J; Williams JE; Winkfield KM; Yang ES; Zwicker V; Pierce LJ
J Clin Oncol; 2022 Jul; 40(19):2163-2171. PubMed ID: 35588469
[TBL] [Abstract][Full Text] [Related]
6. Overcoming Disparities in Cancer: A Need for Meaningful Reform for Hispanic and Latino Cancer Survivors.
Kronenfeld JP; Graves KD; Penedo FJ; Yanez B
Oncologist; 2021 Jun; 26(6):443-452. PubMed ID: 33594785
[TBL] [Abstract][Full Text] [Related]
7. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
8. Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients.
Lee EQ; Weller M; Sul J; Bagley SJ; Sahebjam S; van den Bent M; Ahluwalia M; Campian JL; Galanis E; Gilbert MR; Holdhoff M; Lesser GJ; Lieberman FS; Mehta MP; Penas-Prado M; Schreck KC; Strowd RE; Vogelbaum MA; Walbert T; Chang SM; Nabors LB; Grossman S; Reardon DA; Wen PY
Neuro Oncol; 2020 May; 22(5):601-612. PubMed ID: 31974566
[TBL] [Abstract][Full Text] [Related]
9. Improved clinical trial race/ethnicity reporting and updated inclusion profile, 2017-2022: A New Jersey snapshot.
Paleoudis EG; Han Z; Gelman S; Arias-Ruiz H; Carter D; Bertrand J; Mastrogiovanni N; Terlecky SR
Glob Epidemiol; 2024 Jun; 7():100134. PubMed ID: 38259323
[TBL] [Abstract][Full Text] [Related]
10. Increasing accrual of minority patients in breast cancer clinical trials.
Trant AA; Walz L; Allen W; DeJesus J; Hatzis C; Silber A
Breast Cancer Res Treat; 2020 Nov; 184(2):499-505. PubMed ID: 32840699
[TBL] [Abstract][Full Text] [Related]
11. A framework for setting enrollment goals to ensure participant diversity in sponsored clinical trials in the United States.
Cullen MR; Lemeshow AR; Amaro S; Bandera EV; Cooper LA; Kawachi I; Lunyera J; McKinley L; Poss CS; Rottas MM; Schachterle SE; Thadeio PF; Russo LJ
Contemp Clin Trials; 2023 Jun; 129():107184. PubMed ID: 37054773
[TBL] [Abstract][Full Text] [Related]
12. Response Assessment in Neuro-Oncology Clinical Trials.
Wen PY; Chang SM; Van den Bent MJ; Vogelbaum MA; Macdonald DR; Lee EQ
J Clin Oncol; 2017 Jul; 35(21):2439-2449. PubMed ID: 28640707
[TBL] [Abstract][Full Text] [Related]
13. Involving South Asian patients in clinical trials.
Hussain-Gambles M; Leese B; Atkin K; Brown J; Mason S; Tovey P
Health Technol Assess; 2004 Oct; 8(42):iii, 1-109. PubMed ID: 15488164
[TBL] [Abstract][Full Text] [Related]
14. Data-driven strategies for increasing patient diversity in Bristol Myers Squibb-sponsored US oncology clinical trials.
Kuri L; Setru S; Liu G; Reed DM; Weigand D; Surampudi A; Berger S; Paulucci D; Rai A; Sethuraman V; Vito B; Kellar-Wood H; Balan MM
Clin Trials; 2023 Dec; 20(6):585-593. PubMed ID: 37309819
[TBL] [Abstract][Full Text] [Related]
15. Delivering Equitable Care to Underserved Neuro-oncology Populations.
Porter AB; Chukwueke UN; Mammoser AG; Friday B; Hervey-Jumper S
Am Soc Clin Oncol Educ Book; 2021 Mar; 41():1-9. PubMed ID: 33830829
[TBL] [Abstract][Full Text] [Related]
16. Community engagement and clinical trial diversity: Navigating barriers and co-designing solutions-A report from the "Health Equity through Diversity" seminar series.
Reopell L; Nolan TS; Gray DM; Williams A; Brewer LC; Bryant AL; Wilson G; Williams E; Jones C; McKoy A; Grever J; Soliman A; Baez J; Nawaz S; Walker DM; Metlock F; Zappe L; Gregory J; Joseph JJ
PLoS One; 2023; 18(2):e0281940. PubMed ID: 36795792
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. Minority Enrollment to Clinical Trials: Road to Increased Access.
Vose J
Oncology (Williston Park); 2021 Mar; 35(3):107. PubMed ID: 33818053
[TBL] [Abstract][Full Text] [Related]
19. Indigenous peoples and inclusion in clinical and genomic research: Understanding the history and navigating contemporary engagement.
Waanders A; Brown A; Caron NR; Plisiewicz A; McHugh ST; Nguyen TQ; Lehmann K; Stevens J; Storm PJ; Resnick A; Davidson TB; Mueller S; Kline C
Neoplasia; 2023 Mar; 37():100879. PubMed ID: 36738585
[TBL] [Abstract][Full Text] [Related]
20. Barriers and facilitators of clinical trial enrollment in a network of community-based pediatric oncology clinics.
Russo C; Stout L; House T; Santana VM
Pediatr Blood Cancer; 2020 Apr; 67(4):e28023. PubMed ID: 31556250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
